Try one of the below options to narrow down your search.
 |
Documents may be browsed by date, eg; Today, May, 2013.
Past years can be browsed too, eg; 2012, 2011, 2010, 2009 ...
Documents can be searched within a period by browsing to the date and then using the search form; or by direct links, eg; Media releases from 2013
Document tags (shown below the document date, eg; Schedule, SAForms, consultation ...) have highest priority when search results are ranked, followed by title, abstract and full text of document.
Parentheses and the keywords and, or and not have special meaning in search terms. And is implicit and can be omitted; or must be specified.
Remember to group or statements with parentheses if they are beside and statements.
Search examples
- consultation
- Search for consultations
- media and not antibiotics
- Search for media related documents that don't mention antibiotics.
- (media or consultation) and vaccines
- Search for media releases and consultation documents mentioning vaccinations.
Search term: consultation
2011
PHARMAC documents that matched your search:
Proposal to widen access to docetaxel; Closing Date: Closed; Contact: Jackie Evans
(4 pages, 135 KB)
2011/05/20
20 May 2011 Proposal to widen access to docetaxel PHARMAC is seeking feedback on a proposal to widen funded access to the Pharmaceutical Cancer Treatment docetaxel from 1 July 2011 by removing the Special Authority restrictions that currently apply to…
Proposal to list new brand of propofol in Section H; Closing Date: Closed; Contact: Andrew Davies
(1 page, 105 KB)
2011/05/06
6 May 2011 Proposal to list a new brand of propofol in Section H PHARMAC is seeking feedback on a proposal to list the Fresofol brand of propofol 10 mg per ml injection in Part II of Section H from…
Various Musculoskeletal System pharmaceuticals; Closing Date: Closed; Contact: Geraldine MacGibbon
(3 pages, 133 KB)
2011/04/27
27 April 2011 Proposal involving various Musculoskeletal System pharmaceuticals PHARMAC is seeking feedback on a proposal to make the following changes to pharmaceuticals within the “Musculoskeletal System” therapeutic group of the Pharmaceutical Schedule from 1 July 2011: Fully fund…
Proposal to fund dabigatran (Pradaxa); Closing Date: Closed; Contact: Sue Anne Yee
(3 pages, 138 KB)
2011/04/08
8 April 2011 Proposal to fund dabigatran (Pradaxa) PHARMAC is seeking feedback on a proposal to fund dabigatran. Dabigatran is an oral anticoagulant approved for use in: o o Atrial fibrillation; and Prevention of venous thromboembolism post major orthopedic surgery.…
Proposal to fund olanzapine depot injection, teriparatide and raloxifene; Closing Date: Closed; Contact: Geraldine MacGibbon
(5 pages, 143 KB)
2011/04/05
5 April 2011 Proposal to fund olanzapine depot injection, teriparatide and raloxifene PHARMAC is seeking feedback on a proposal to fund a new depot antipsychotic injection and two new treatments for osteoporosis from 1 July 2011 through a provisional agreement…
Proposal to list generic venlafaxine; Closing Date: Closed; Contact: Geraldine MacGibbon
(1 page, 111 KB)
2011/04/05
5 April 2011 Proposal to list generic venlafaxine PHARMAC is seeking feedback on a proposal to list a generic version of the antidepressant venlafaxine hydrochloride (Arrow-Venlafaxine XR), through a provisional agreement with Arrow Pharmaceuticals (NZ) Limited, as follows: Arrow-Venlafaxine…
Pharmacy Consultation Schedule March 2011; Closing Date: Closed
(2 pages, 25 KB)
2011/03/07
PHARMACY CONSULTATION SCHEDULE March 2011 DATE 6-8 pm Monday 7 March 6.30-8.30 pm Tuesday 8 March 6.30-8.30 pm Tuesday 8 March 6.30-8.30 pm Wednesday 9 March 6-8 pm Wednesday 9 March 8–10 am Thursday 10 March 6-8 pm Thursday 10…
Pharmacy Rules, extending consultation deadline; Closing Date: Closed
(1 page, 108 KB)
2011/03/04
4 March 2010 Dear Colleagues The Canterbury earthquake has required an extraordinary response from health professionals and providers both in Canterbury and from colleagues around New Zealand. We are all immensely grateful for your skills and commitment to our people…
Proposal to list a new brand of ornidazole; Closing Date: Closed; Contact: Greg Williams
(2 pages, 120 KB)
2011/02/25
25 February 2011 Proposal to list a new brand of ornidazole PHARMAC is seeking feedback on a provisional agreement it has reached with Arrow Pharmaceuticals (NZ) Limited. In summary, the proposal is to fund Arrow-Ornidazole tablets from 1 May 2011.…
Proposal for nilotinib and imatinib; Closing Date: Closed; Contact: Jackie Evans
(6 pages, 153 KB)
2011/02/24
24 February 2011 Proposal to widen funded access to imatinib and to fund nilotinib for patients with CML PHARMAC is seeking feedback on a proposal to: fund nilotinib (Tasigna) for patients with chronic myeloid leukaemia (CML); and widen…
